# Effects of CreaSafe® on Kidney, Muscle, and Cardiopulmonary Function in Athletes and COPD Patients

> **NCT06991426** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Federal University of São Paulo** · enrollment: 140 (estimated)

## Conditions studied

- Copd
- Athletes

## Interventions

- **DIETARY_SUPPLEMENT:** CreaSafe® creatine
- **COMBINATION_PRODUCT:** Placebo 0.03 g/kg/day

## Key facts

- **NCT ID:** NCT06991426
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2025-09
- **Final completion:** 2025-10
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991426, "Effects of CreaSafe® on Kidney, Muscle, and Cardiopulmonary Function in Athletes and COPD Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06991426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*